U.S. pharma giant copyright scrapped two experimental weight loss pills past yr—a when-each day pill, lotiglipron, because of elevated liver enzymes in addition to a twice-every day pill, danuglipron, as a result of sturdy side effects—but CEO Albert Bourla has reported the company is set to “Enjoy and win” during the obesity House As well